GlassScriptPhysician profile
Amber D Fowler
NPI 1093733495
$1,109.04
in general payments reported to CMS, 2019-2025
16 companies · $391 in 2025
The $391 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.52 · 2020: $29.16 · 2021: $46.53 · 2022: $129 · 2023: $114 · 2024: $375 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.20 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $211.73 | 2023-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $181.34 | 2022-2025 | Libtayo, Dupixent |
| Sun Pharmaceutical Industries INC. | $146.24 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.99 | 2020-2022 | |
| Abbvie INC. | $122.23 | 2023-2025 | |
| Janssen Biotech, INC. | $77.63 | 2023-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $62.21 | 2023-2025 | |
| Organon LLC | $39.82 | 2025 | Vtama |
| Incyte Corporation | $21.79 | 2024 | Opzelura |
| Genzyme Corporation | $20.66 | 2024 | |
| Leo Pharma INC. | $20.26 | 2025 | Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $18.09 | 2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $16.85 | 2024 | Zoryve |
| Galderma Laboratories, L.P. | $14.68 | 2025 | Aklief |
| Phadia US INC. | $13.46 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.